SEMAGLUTIDE, 10 mg
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist that has fundamentally changed the landscape of metabolic medicine. Originally designed for Type 2 Diabetes, it is now widely used for chronic weight management and cardiovascular protection.
It works by mimicking a natural hormone released in the gut after eating, which signals the brain to feel full and tells the pancreas to manage blood sugar more effectively.
Key Benefits of Semaglutide
As of 2026, the clinical understanding of Semaglutide has expanded to include several "off-target" benefits that go beyond simple weight loss:
-
Significant Weight Reduction: It is highly effective for weight loss by slowing gastric emptying (keeping food in the stomach longer) and "quieting" what many users call "food noise"—the persistent, intrusive thoughts about eating.
-
Cardiovascular Protection: Major studies (like the SELECT trial) have shown that Semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by roughly 20%, even in people without diabetes.
-
Blood Sugar Stabilization: For those with insulin resistance or diabetes, it improves HbA1C levels by enhancing insulin secretion and suppressing glucagon (the hormone that raises blood sugar).
-
Liver Health (MASH/NASH): In early 2026, the FDA granted accelerated approval for Semaglutide to treat Metabolic Dysfunction-Associated Steatohepatitis (MASH), as it has been shown to reduce liver fat and inflammation.
-
Kidney Protection: It helps reduce the risk of kidney function decline and failure in patients with Type 2 Diabetes and chronic kidney disease.
-
Emerging Neuroprotective & Addiction Benefits: New research in 2025–2026 suggests it may reduce cravings for alcohol and nicotine and is being studied for its potential to slow the progression of neurodegenerative diseases like Alzheimer’s.